Medical Device Stocks Fall Sharply on HCA's Weak Surgical Volume Warning

Shares of major medical device manufacturers tumbled on Tuesday after HCA Healthcare, one of the largest U.S. hospital operators, released preliminary second-quarter results that pointed to weaker-than-expected surgical volumes.

The news triggered a broad sell-off across the sector, as investors worried that a slowdown in procedures would directly impact demand for medical equipment and supplies.

Sector-Wide Sell-Off

The market reaction was swift and widespread, with significant declines among leading medical technology firms. The sell-off reflects concerns that HCA's results could be a bellwether for the broader healthcare industry.

Key stock movements included:

Ad

• GE Healthcare (GEHC): dropped 7%
• Intuitive Surgical (ISRG): declined 6%
• Stryker (SYK): fell 5.4%
• Medtronic (MDT): dropped 4.7%
• Zimmer Biomet (ZBH): declined 3%

Analyst Outlook

According to Wells Fargo analyst Larry Biegelsen, the medical technology sector is expected to face pressure following HCA's announcement. He anticipates the topic will be a key point of discussion during upcoming second-quarter earnings calls for device manufacturers.

Biegelsen noted that the weakness appears concentrated in elective procedures for patients under 65, particularly in areas like orthopedics and spine surgery. In contrast, non-elective procedures typically performed on patients over 65, such as cardiovascular treatments, seem less exposed to the slowdown, according to the analyst's commentary.